Synthesis, in vivo rhesus monkey biodistribution and in vitro evaluation of a 11c-labelled potent aromatase inhibitor: [N-methyl-11C]Vorozole

Nuclear Medicine and Biology

Volumn 25, Issue 5, 1998, Pages 497-501

  Lidström, Pelle ^a   Bonasera, Thomas A ^a   Kirilovas, Dmitrijus ^b   Lindblom, Bo ^b   Lu, Li ^a   Bergström, Elisabeth ^a   Bergström, Mats ^a   Westlin, Jan Erik ^a   Långström, Bengt ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b Dept of Obstetrics and Gynaecology   (Sweden)

Author keywords

N methyl 11C Vorozole; Aromarase; Biodistribution; Inhibitor

Indexed keywords

AROMATASE INHIBITOR; CARBON 11; METHYL IODIDE; UNCLASSIFIED DRUG; VOROZOLE; VOROZOLE C 11;

ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BINDING KINETICS; DRUG DISTRIBUTION; DRUG SPECIFICITY; DRUG SYNTHESIS; DRUG UPTAKE; ENZYME BINDING; HUMAN; HUMAN TISSUE; NONHUMAN; PLACENTA; POSITRON EMISSION TOMOGRAPHY; RADIOACTIVITY; RHESUS MONKEY; TISSUE SPECIFICITY;

ANIMALS; AROMATASE INHIBITORS; AUTORADIOGRAPHY; ENZYME INHIBITORS; HUMANS; MACACA MULATTA; PLACENTA; SWINE; TISSUE DISTRIBUTION;

EID: 0032125597     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(98)00009-2     Document Type: Article

References (19)

1. Bjurling P., Reineck R., Westerberg G., Schultz J., Gee A., Sutcliffe J. et al. (August 1995) Proceedings of the Sixth Workshop on Targetry and Target Chemistry, p. 282. Vancouver, Canada.
2. Brodie A. Steroidogenesis pathway enzymes. Sandler M., Harold J. Design of Enzyme Inhibiting Drugs, Volume 2. 1994;414-423 Oxford University Press, Oxford.
3. Brodie A. M. H. Aromatase inhibitors in the treatment of breast cancer. J. Steroid Biochem. Molec. Biol. 49:1994;281-287.
4. Brodie A. M. H., Banks P. K., Inkster S. E., Dowsett M., Coombes R. C. Aromatase inhibitors and hormone-dependent cancers. J. Steroid Biochem. 37:1990;327-333.
5. Cole P., Robinson C. H. Mechanism and inhibition of cytochrome P-450 aromatase. J. Med. Chem. 33:1990;2933-2942.
6. Coombes R. C., Goss P., Dowsett M., Gazet J. C. and Brodie A. M. H. (1984) 4-Hydroxyandostendione treatment of postmenopausal patients with advanced breast cancer. Lancet ii, 1237-1239.
7. De Coster R., Wouters W., van Ginckel R., Tuman R., Bowden C., Bruynseels J. Pharmacology of vorozole, a new potent and selective non-steroidal aromatase inhibitor. Rubustelli della Cuna G. Clinical Use of Aromatase Inhibitors - Current Data and Future Perspectives. 1994;173-177 Edizioni Medico-Scientifiche-Pavia, Pavia, Italy.
8. Dowsett M., Jones A., Johnston S. R. D., Jacobs S., Trunet P., Smith I. E. In vivo measurement of aromatase inhibition by letrozole (CGS 20267) in postmenopausal patients with breast cancer. Clin. Cancer Res. 1:1995;1511-1515.
9. Dowsett M., Harris A. L., Stuart-Harris R., et al. A comparison of the endocrine effects of low dose aminoglutethimide with and without hydrocortisone in postmenopausal breast cancer patients. Br. J. Cancer. 52:1985;525-529.
10. 11C)harmine in frozen section autoradiography. Oncol. Reports. 2:1995;717-721.
11. 11C]methionine. J. Nucl. Med. 28:1987;1037-1040.
12. Plourde P. V., Dyroff M., Dowsett M., Demers L., Yates R., Webster A. Arimidex A new oral, once-a-day aromatase inhibitor . J. Steroid Biochem. Mol. Biol. 53:1995;175-179.
13. Santen R. J., Worgul T. J., Lipton A., Harvey H. A., Boucher A., Samojlik E., et al. Aminoglutethimide as treatment of postmenopausal women with advanced breast carcinoma Correlation of clinical and hormonal responses . Annals Intern. Med. 96:1982;94-101.
14. 11C)Ro 15-1788 . Nucl. Med. Biol. 24:1997;723-731.
15. Smith I. E., Harris A. L., Morgan M., et al. Tamoxifen versus aminoglutethimide in advanced breast carcinoma A randomised cross-over trial . Br. Med. J. 283:1981;1432-1434.
16. Schwarzel W. C., Kruggel W., Brodie H. J. Studies on the mechanism of estrogen biosynthesis VII. Development of inhibitors of the enzyme system in human placenta . Endocrinology. 92:1973;866-880.
17. Wouters W., Snoeck E., De Coster R. Vorozole, a specific non-steroidal aromatase inhibitor. Breast Cancer Res. Treat. 30:1994;89-94.
18. Wouters W., De Coster R., van Dun J., et al. Comparative effects of the aromatase inhibitor R 76 713 and of its enantiomers R 83 839 and R 83 842 on steroid biosynthesis in vitro and in vivo. J. Steroid Biochem. Molec. Biol. 37:1990;1049-1054.
19. 3H)-labelled ligands visualized by imaging plates. Neuroreport. 3:1992;961-964.